Amlodipine/benazepril, marketed in the U.S. as Lotrel by Novartis and manufactured as a generic drug by Teva, is an antihypertensive medication which combines a calcium channel blocker with an angiotensin converting enzyme inhibitor. This combination agent, and other analogs, is prescribed when either agent alone is not sufficient to bring a person's blood pressure down to target range. As a combination agent, Lotrel shares the adverse reaction profile of both of its individual parts.

PropertyValue
dbpedia-owl:Drug/pubchem
  • 5746247
dbpedia-owl:pubchem
  • 5746247
dbpedia-owl:thumbnail
dbpprop:abstract
  • Amlodipine/benazepril, marketed in the U.S. as Lotrel by Novartis and manufactured as a generic drug by Teva, is an antihypertensive medication which combines a calcium channel blocker with an angiotensin converting enzyme inhibitor. This combination agent, and other analogs, is prescribed when either agent alone is not sufficient to bring a person's blood pressure down to target range. As a combination agent, Lotrel shares the adverse reaction profile of both of its individual parts.
dbpprop:class
dbpprop:component
  • Amlodipine
  • Benazepril
dbpprop:hasPhotoCollection
dbpprop:image
  • Benazepril.svg
dbpprop:legalUs
  • Rx-only
dbpprop:pregnancyCategory
  • C
dbpprop:pubchem
  • 5746247 (xsd:integer)
dbpprop:routesOfAdministration
  • Oral
dbpprop:type
  • combo
dbpprop:wikiPageUsesTemplate
rdf:type
rdfs:comment
  • Amlodipine/benazepril, marketed in the U.S. as Lotrel by Novartis and manufactured as a generic drug by Teva, is an antihypertensive medication which combines a calcium channel blocker with an angiotensin converting enzyme inhibitor. This combination agent, and other analogs, is prescribed when either agent alone is not sufficient to bring a person's blood pressure down to target range. As a combination agent, Lotrel shares the adverse reaction profile of both of its individual parts.
rdfs:label
  • Amlodipine/benazepril
owl:sameAs
skos:subject
foaf:depiction
foaf:page
is dbpprop:redirect of